Kerri FitzgeraldAggressive B-Cell Lymphoma | September 13, 2022
Pola-R-CHP may be cost-effective for the treatment of DLBCL.
Read More
Leah SherwoodAcute Lymphoblastic Leukemia | July 15, 2022
A new study found that more than one-third of patients aged older than 65 years do not receive...
Leah SherwoodAggressive B-Cell Lymphoma | June 21, 2022
The phase III GALLIUM study confirmed obinutuzumab plus chemotherapy as a standard of care for first-line follicular lymphoma
Sabrina AhleAcute Lymphoblastic Leukemia | February 8, 2022
Researchers have discovered that chemotherapy and COVID-19 infection cause neuro-inflammation in similar ways.
Editorial Board